KRRO (STOCKS)
Korro Bio, Inc. Common Stock
$13.690000
+1.010000 (+7.97%)
Prev close: $12.680000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- CEO
- Ram Aiyar
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $197.16M
- Employees
- 92
- P/E (TTM)
- -1.10
- P/B (TTM)
- 2.32
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $6.39M |
| Benefits Costs and Expenses | $123.02M |
| Costs And Expenses | $123.02M |
| Operating Expenses | $128.25M |
| Research and Development | $65.58M |
| Other Operating Expenses | $62.67M |
| Operating Income/Loss | -$121.86M |
| Income/Loss From Continuing Operations After Tax | -$117.26M |
| Income/Loss From Continuing Operations Before Tax | -$116.62M |
| Income Tax Expense/Benefit | $637.00K |
| Income Tax Expense/Benefit, Current | $637.00K |
| Income Tax Expense/Benefit, Deferred | $0.00 |
| Net Income/Loss | -$117.26M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$117.26M |
| Net Income/Loss Available To Common Stockholders, Basic | -$117.26M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$12.48 |
| Diluted Earnings Per Share | -$12.48 |
| Basic Average Shares | 9,395,402 |
| Diluted Average Shares | 9,395,402 |
| Assets | $113.51M |
| Current Assets | $82.37M |
| Noncurrent Assets | $31.13M |
| Fixed Assets | $8.16M |
| Other Non-current Assets | $22.97M |
| Liabilities | $62.07M |
| Current Liabilities | $11.94M |
| Accounts Payable | $1.65M |
| Other Current Liabilities | $10.29M |
| Noncurrent Liabilities | $50.13M |
| Equity | $51.44M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $51.44M |
| Liabilities And Equity | $113.51M |
| Net Cash Flow From Operating Activities | -$78.56M |
| Net Cash Flow From Operating Activities, Continuing | -$78.56M |
| Net Cash Flow From Investing Activities | $43.99M |
| Net Cash Flow From Investing Activities, Continuing | $43.99M |
| Net Cash Flow From Financing Activities | $685.00K |
| Net Cash Flow From Financing Activities, Continuing | $685.00K |
| Exchange Gains/Losses | $64.00K |
| Net Cash Flow | -$33.82M |
| Net Cash Flow, Continuing | -$33.88M |
| Comprehensive Income/Loss | -$117.32M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$117.32M |
| Other Comprehensive Income/Loss | -$56.00K |